Fluad, a flu vaccine that's linked to Gulf War Syndrome has been approved by the FDA. This, despite the long list of negative side effects. The controversial move seems to be in line with the FDA's accelerated approval process of pharmaceutical products despite the dangers of certain drugs.
Fluad uses squalene as an adjuvant, a health food that's full of antioxidants. However, since squalene is received by the body through an abnormal route, the system creates antibodies to resist the vaccine. This may be detrimental to the health.
The flu shot in question, which uses squalene as an adjuvant, is FLUAD. It was first approved in 2015, and now has a 2017-2018 formula.
Here is its full list of ingredients:
Adjuvants: squalene, polysorbate 80, sorbitan trioleate, sodium citrate, citric acid, water for injection. Excipients: sodium chloride, potassium chloride, potassium dihydrogen phosphate, disodium phosphate dehydrate, magnesium chloride hexahydrate, calcium chloride dehydrate, and water.
It can also contain trace amounts of: neomycin, kanamycin, ovalbumin (egg protein), formaldehyde, cetyltrimethylammonium bromide (CTAB), and barium.
Besides the controversial squalene, its other ingredients are also concerning. Formaldehyde has been associated with increased cancer risk; potassium chloride linked to paralysis; neomycin to difficulties breathing.
The vaccine’s post marketing experience reports include:
-Nervous system disorders
-Encephalomyelitis (inflammation of the brain)
Accelerated Approval of Vaccines Is a Huge Issue
Another issue is that Fluad has been approved on an accelerated schedule, something that is becoming common with vaccinations (many may begin coming from China because of an agreement the Clinton Foundation made as well).
Image courtesy of: Noro8